<info type="ChemicalEntity">Atorvastatin</info> prevented and reversed <info type="ChemicalEntity">dexamethasone</info>-induced <info type="DiseaseOrPhenotypicFeature">hypertension</info> in the <info type="OrganismTaxon">rat</info>.

To assess the antioxidant effects of <info type="ChemicalEntity">atorvastatin</info> (<info type="ChemicalEntity">atorva</info>) on <info type="ChemicalEntity">dexamethasone</info> (<info type="ChemicalEntity">dex</info>)-induced <info type="DiseaseOrPhenotypicFeature">hypertension</info>, 60 male <info type="OrganismTaxon">Sprague-Dawley rats</info> were treated with <info type="ChemicalEntity">atorva</info> 30 mg/kg/day or tap water for 15 days. <info type="ChemicalEntity">Dex</info> increased systolic blood pressure (SBP) from 109 +/- 1.8 to 135 +/- 0.6 mmHg and plasma <info type="ChemicalEntity">superoxide</info> (5711 +/- 284.9 saline, 7931 +/- 392.8 U/ml <info type="ChemicalEntity">dex</info>, P < 0.001). In this prevention study, SBP in the <info type="ChemicalEntity">atorva</info> + <info type="ChemicalEntity">dex</info> group was increased from 115 +/- 0.4 to 124 +/- 1.5 mmHg, but this was significantly lower than in the <info type="ChemicalEntity">dex</info>-only group (P' < 0.05). <info type="ChemicalEntity">Atorva</info> reversed <info type="ChemicalEntity">dex</info>-induced <info type="DiseaseOrPhenotypicFeature">hypertension</info> (129 +/- 0.6 mmHg, vs. 135 +/- 0.6 mmHg P' < 0.05) and decreased plasma <info type="ChemicalEntity">superoxide</info> (7931 +/- 392.8 <info type="ChemicalEntity">dex</info>, 1187 +/- 441.2 <info type="ChemicalEntity">atorva</info> + <info type="ChemicalEntity">dex</info>, P < 0.0001). Plasma <info type="ChemicalEntity">nitrate/nitrite</info> (NOx) was decreased in <info type="ChemicalEntity">dex</info>-treated <info type="OrganismTaxon">rats</info> compared to saline-treated <info type="OrganismTaxon">rats</info> (11.2 +/- 1.08 microm, 15.3 +/- 1.17 microm, respectively, P < 0.05). <info type="ChemicalEntity">Atorva</info> affected neither plasma <info type="ChemicalEntity">NOx</info> nor <info type="CellLine">thymus weight</info>. Thus, <info type="ChemicalEntity">atorvastatin</info> prevented and reversed <info type="ChemicalEntity">dexamethasone</info>-induced <info type="DiseaseOrPhenotypicFeature">hypertension</info> in the <info type="OrganismTaxon">rat</info>.